Drug · DIN 02243763
COMTAN
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since September 8, 2023; first marketed June 21, 2001.
- Drug Identification Number (DIN)
- 02243763
- Company (DIN owner)
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Entacapone N04BX02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ENTACAPONE | 200 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 23, 2020: NOC 23942New Drug Submission (NDS) · Administrative: Change in Product Ownership
- May 8, 2001: NOC 2228New Drug Submission (NDS)